Related Experiment Video
Updated: Feb 20, 2026
05:18
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
86
Heart transplantation in pediatric age
Ornella Milanesi1, Alessia Cerutti, Roberta Biffanti
1Department of Pediatrics, University of Padova School of Medicine, Padova, Italy. ornella.milanesi@unipd.it
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|January 27, 2007
Summary
Pediatric heart transplantation is a vital treatment for severe heart conditions, but donor shortages and long-term immunosuppression effects pose significant challenges for children and families.
Area of Science:
- Cardiology
- Pediatric Surgery
- Immunology
Background:
- Heart transplantation is increasingly the primary treatment for pediatric cardiac conditions unresponsive to conservative care.
- It offers a life-saving option for terminally ill children with severe heart failure.
Observation:
- A critical shortage of pediatric heart donors persists globally, particularly for infants.
- Long-term immunosuppression in developing children presents complex health challenges.
- The interplay between immunosuppression and the original cardiac condition requires further investigation.
Findings:
- Despite advancements, donor organ scarcity remains a major obstacle in pediatric heart transplantation.
- The lifelong impact of immunosuppressive therapy on a child's growth and development is a significant concern.
- The long-term efficacy and potential complications of heart transplants in children are still under evaluation.
Implications:
- Addressing the pediatric donor shortage is crucial for expanding access to heart transplantation.
- Further research into optimizing immunosuppression protocols is needed to mitigate long-term risks.
- Understanding the long-term outcomes is essential for managing patient and family expectations regarding heart transplantation as a cure versus an ongoing condition.
